Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04781491
Other study ID # Wald
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 27, 2022
Est. completion date December 2024

Study information

Verified date October 2023
Source Charite University, Berlin, Germany
Contact Miriam Rösner
Phone 00493080505682
Email m.roesner@immanuel.de
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to investigate the effects of regular forest therapy under guidance of a licensed nature therapist on patients with metabolic syndrome and cardiovascular risks


Description:

It is assumed that nature and forest experience has sustainable benefits for the physical and mental health of individuals with metabolic syndrome and cardiovascular risk profile. Especially co-therapeutic effects in terms of resilience and salutogenesis might effectively and sustainably promoted by nature and forest therapy. The main objective of this study is to measure the effects of nature and forest therapy in subjects with manifest metabolic syndrome and cardiovascular risk factors. The intervention is a stay in the nature of the Düppeler Forest (Berlin-Wannsee) under the guidance of trained nature guides (90 minutes, 1x/week over 2 months), who teach exercises on the perception of nature and the connection between nature and health, movement and mindfulness. Subjects are also motivated to experience forest nature as regularly as possible (recommended ≥ 30 minutes daily). Participants of the control group will be offered a later participation in the therapy program after completion of the last study visit after 4 months (waiting list control group).


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Definition of Metabolic Syndrome according to the International Diabetes Foundation (IDF): - waist circumference: at least 94 cm for men, at least 80 cm for women - plus at least two of the following risk factors: - fasting blood glucose levels of > 100 mg/dl (> 5.6 mmol/l) measured in blood plasma or diagnosed diabetes mellitus - elevated triglycerides > 150 mg/dl (> 1.7 mmol/l) or therapy already initiated to lower triglycerides - low HDL cholesterol: < 40 mg/dl (< 1.05 mmol/l) in men and < 50 mg/dl (< 1.25 mmol/l) in women or already initiated therapy to increase HDL - Hypertension (from > 130 mmHg systolic and > 85 mmHg diastolic) or already treated hypertension Exclusion Criteria: - Serious acute or chronic illnesses - Immobility or limitation of mobility due to orthopedic, neurological or other medical cause - Participation in another study - Serious mental illness - Pregnancy and lactation

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Forest Therapy (Düppeler Forst - Berlin-Wannsee)
Forest Therapy means mindful visits in nature, actively perceiving the flora and fauna

Locations

Country Name City State
Germany Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus Berlin

Sponsors (1)

Lead Sponsor Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Other - Blood count Laboratory parameters Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Other - Blood lipids (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides) Laboratory parameters Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Other - Parameters of glucose metabolism (insulin, glucose, HbA1C, insulin sensitivity) Laboratory parameters will be combined to report Diabetes status Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Other - liver function (GOT, GPT, GGT) Laboratory parameters Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Other - Inflammation: hs-CRP, IL-6 Laboratory parameters Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Other - IFN-gamma, tumor necrosis factor alpha Laboratory parameters Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Other - uric acid Laboratory parameters Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Other - Lymphocyte populations: T cells (CD3), B cells (CD19), NK cells (CD16). Laboratory parameters Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Other - T cell subpopulations: T helper cells (CD4), cytotoxic T cells (CD8), CD4/CD8 ratio. Laboratory parameters Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Other - ferritin Laboratory parameters Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Other - cumulative steroid hormone concentration of the last 2 months in a hair strand Laboratory parameters Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Other • Apparatus parameters Body weight
abdominal girth
blood pressure measurement (24h) will be combined to report metabolic syndrome
Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Other • Qualitative evaluation (focus group interviews) - Semi-structured interviews and focus group discussions with 16 subjects of the intervention group. Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Other • Heart rate variability and other parameters - Digital tracking using "wearables": parameters of stress levels and activity and sleep patterns are measured objectively using a smartwatch (fitbit). Heart rate variability (RMSSD), pulse, activity duration, type, and intensity as well as sleep duration, sleep phases, steps, and calorie consumption are recorded. The aim is to test whether the activity and pulse tracking data provide information about the variance in quality of life data. Will be combined to report quality of life. Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Other - bioelectrical impedance analysis (BIA) Estimation of the body composition via bio-electrical impedance analysis (muscle mass in kg) Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Other Heart Rate (HR) 24h measuring by smartwatch Date of inclusion (baseline), after 8 weeks, after 16 weeks
Other Heart Rate Variability (HRV) 24h measuring by smartwatch Date of inclusion (baseline), after 8 weeks, after 16 weeks
Other Interbeat Interval (IBI) 24h measuring by smartwatch Date of inclusion (baseline), after 8 weeks, after 16 weeks
Other Number of steps 24h measuring by smartwatch Date of inclusion (baseline), after 8 weeks, after 16 weeks
Primary • Final sum score of cardiovascular risk profile (overweight, blood pressure, blood lipids, blood glucose) according to Wiley/Carrington Date of Inclusion (Baseline), after 8 weeks and after 16 weeks
Secondary • Perceived Stress Scale (PSS) Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived•stress. Higher score meaning more stress Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Secondary • Short Form 12 Health Survey (SF-12) The Short Form (12) Health Survey is a 12-item, patient-reported survey of patient health.The World Health Organisation- Five Well-Being Index (WHO-5) is a short self-reported measure of current mental wellbeing. score ranging from 0-5 for each question, lower score meaning a better outcome. Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Secondary • Physical complaints (B-LR - Beschwerden-Liste) the Complaints List - (B-LR) is a self-assessment procedure for recording subjective impairment due to physical or general complaints, covering the entire spectrum from no complaints to severe impairment. Two parallel forms (B-LR and B-LR') are available, each consisting of 20 items, lower score meaning a better outcome Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Secondary • Flourishing Scale (FS-D) The Flourishing Scale is a brief 8-item summary measure of the respondent's self-perceived success in important areas such as relationships, self-esteem, purpose, and optimism. The scale provides a single psychological well-being score, ranging from 8-56, higher score meaning a better outcome Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Secondary • Hospital Anxiety and Depression Scale (HADS) Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Secondary • Mindfulness (Freiburger Fragebogen zur Achtsamkeit, FFA) Assessing full scale, range 0-56, higher score meaning a better outcome Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Secondary • General Self-Efficacy Short Scale (ASKU-Allgemeine Selbstwirksamkeit Kurzskala) Measurement instrument for recording subjective competence expectations. Scale ranging from 1-5, higher score meaning a better outcome Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Secondary • International Physical Activity Questionnaire (IPAQ) The 31-item long form and the 9-item short form assess time spent on different activities. The short form records four types of physical activity: vigorous activity such as aerobics; moderate-intensity activity such as leisure cycling; walking, and sitting.
MET minutes represent the amount of energy expended carrying out physical activity. To get a continuous variable score from the IPAQ (MET minutes a week) we will consider walking to be 3.3 METS, moderate physical activity to be 4 METS and vigorous physical activity to be 8 METS; higher score meaning better outcome; range 0 to around 3000 MET minutes a week
Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Secondary • Weekly query of the exercise practice by means of (online) diary Date of Inclusion (Baseline), after 8 weeks and after 16 weeks]
Secondary Subjective Vitality Scale state (SVS-G state) Assessing full scale, range 1-80, higher score meaning a better outcome Date of Inclusion (Baseline), after 8 weeks and after 16 weeks
Secondary Perceived Benefits of Nature Questionnaire (PBNQ) Assessing full scale, range 1-7, lower score meaning a better outcome Date of Inclusion (Baseline), after 8 weeks and after 16 weeks
Secondary Profile of Mood States (POMS) Date of Inclusion (Baseline), after 8 weeks and after 16 weeks
See also
  Status Clinical Trial Phase
Completed NCT04595669 - Personalised Advice for the Prevention of Metabolic Syndrome N/A
Completed NCT02078687 - Growth, Risks of Allergy and Metabolic Syndrome in 6 Year Old Children Born Preterm Compared to Postdischarge Nutrition N/A
Active, not recruiting NCT04053569 - Grape Polyphenols and Metabolic Syndrome N/A
Not yet recruiting NCT06377956 - The Associations Between Gut Length, Gut Microbiota and Food Assimilation
Recruiting NCT05764473 - Diet, Cardiometabolic Risk (CM) and Menopause Symptoms N/A
Recruiting NCT04477590 - Interactions of Medicine and Exercise With Meal Timing N/A
Not yet recruiting NCT06437860 - Nutritional Intervention for Sustaining Health (NURISH) Trial N/A
Not yet recruiting NCT04815538 - The Relationship Between Workplace Environment and Metabolic Syndrome in Different Industries
Completed NCT01925547 - Micellar Curcumin and Metabolic Syndrome Biomarkers Phase 2
Recruiting NCT03994367 - Animal and Plant Proteins and Glucose Metabolism N/A
Recruiting NCT06099288 - Strong Families Start at Home/Familias Fuertes Comienzan en Casa N/A
Active, not recruiting NCT04564586 - Developing and Testing a Technology-Based Translation of the DPP to Address Prediabetes in a Primary Care Setting N/A
Completed NCT05703438 - The Effect of a Low-calorie Diet With Balanced Nutrition on Metabolic Syndrome N/A